...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: debenture

Wow. Koo you nailed it.

A clue, perhaps?

"Over the past several months we have been working diligently with Hepalink in order to prepare for their involvement in our upcoming BETonMACE2 trial which has FDA Breakthrough Therapy Designation"

Share
New Message
Please login to post a reply